Agios Pharmaceuticals, Inc. (AGIO)

Agios Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	2,387	1,245	1,543	1,785	3,001	2,812
Market Cap Growth	29.39%	-19.32%	-13.57%	-40.52%	6.73%	4.81%
Enterprise Value	1,858	540	845	862	2,533	2,360
PE Ratio	-	-3.53	-6.66	1.11	-9.17	-6.83
PS Ratio	81.19	46.40	108.35	-	-	-
PB Ratio	3.21	1.54	1.40	1.38	7.51	4.39
P/FCF Ratio	-5.47	-4.21	-4.92	-4.32	-11.63	-11.33
P/OCF Ratio	-5.46	-4.20	-4.99	-4.38	-12.30	-11.91
EV/Sales Ratio	63.18	20.12	59.37	-	-	-
EV/EBITDA Ratio	-3.32	-1.61	-3.96	0.53	-8.21	-5.98
EV/EBIT Ratio	-3.16	-1.53	-3.65	0.54	-7.74	-5.74
EV/FCF Ratio	-3.71	-1.83	-2.70	-2.09	-9.82	-9.51
Debt / Equity Ratio	0.09	0.09	0.08	0.08	0.26	0.18
Debt / EBITDA Ratio	-0.20	-0.22	-0.40	0.06	-0.34	-0.29
Debt / FCF Ratio	-0.23	-0.24	-0.27	-0.24	-0.41	-0.46
Quick Ratio	11.64	11.47	12.54	17.12	6.07	6.25
Current Ratio	12.84	12.27	13.30	17.79	6.75	6.59
Asset Turnover	0.03	0.03	0.01	0	0	0
Return on Equity (ROE)	-41.40%	-38.10%	-20.70%	95.70%	-63.50%	-73.40%
Return on Assets (ROA)	-36.40%	-33.70%	-18.50%	87.40%	-37.00%	-51.50%
Return on Capital (ROIC)	-48.38%	-44.34%	-21.18%	-26.76%	-66.56%	-41.93%
Earnings Yield	-14.77%	-28.29%	-15.02%	89.89%	-10.91%	-14.63%
FCF Yield	-12.58%	-23.76%	-20.31%	-23.14%	-8.60%	-8.83%
Buyback Yield / Dilution	-2.02%	-1.57%	9.36%	12.39%	-15.01%	-4.49%
Total Shareholder Return	-2.02%	-1.57%	9.36%	12.39%	-15.01%	-4.49%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).